|Year : 2011 | Volume
| Issue : 1 | Page : 34-38
An insight into the swine-influenza A (H1N1) virus infection in humans
Girish L Dandagi1, Sujata M Byahatti2
1 Department of Pulmonary Medicine, KLE'S Jawaharlal Nehru Medical College and Research Centre, Belgaum, Karnataka, India
2 Department of Oral Medicine and Radiology, Maratha Mandals N.G. Halgekar Institute of Dental Sciences and Reaserch Centre, Belgaum, Karnataka, India
|Date of Web Publication||31-Jan-2011|
Girish L Dandagi
Plot No 49, Sector # 9, Malmaruti Extn, Belgaum - 590 016, Karnataka
Source of Support: None, Conflict of Interest: None
| Abstract|| |
WHO declares on June 11, 2009, that H1N1 (Swine-influenza A) is pandemic. There have been nearly 30,000 confirmed H1N1 cases across 74 countries. The reports have shown sharp increase in the number of infections reported in recent days from Chile, Japan, and the UK, and other parts of the world, with the most dramatic increase recorded in Australia where more than 1200 cases were reported in a very short duration. As per the latest report of the Ministry of Health and Family Welfare, death from swine flu has reached to 1235. Around 12,3397 people have been tested in India as on February 1, 2010. In India, 23.3% of people who have tested for swine flu are found suffering from swine flu. Also around 4% of people who have tested positive for swine flu have died and could not be saved in India. The New York Times has reported that this is the first flu for being pandemic in the last 41 years. This article enlightens the brief review about the swine influenza virus, its modes of spread, and prevention measures. The aim of this article is to bring awareness in general and know the consequences of the infection.
Keywords: H1N1 influenza, pig flue, swine flu, swine influenza in humans, H1N1, India, vaccine
|How to cite this article:|
Dandagi GL, Byahatti SM. An insight into the swine-influenza A (H1N1) virus infection in humans. Lung India 2011;28:34-8
| Introduction|| |
Swine influenza is a highly contagious acute respiratory disease of pigs,  caused by one of the several strains of swine influenza A. The virus is spread among pigs by aerosols, through direct and indirect contact, and also by asymptomatic carrier pigs. Swine influenza seen predominantly in the mid-western United States (and occasionally in other states), Mexico, Canada, South America, Europe (including UK, Sweden, and Italy), Kenya, Mainland China, Taiwan, Japan, and other parts of eastern Asia and in various parts of India. In humans, the symptoms of swine flu are similar to those of influenza namely chills, fever, sore throat, muscle pains, severe headache, coughing, weakness, and general discomfort. WHO  says that no previous pandemic disease has been detected so early or watched so closely, in real-time, right at the very beginning. The world can now reap the benefits of investments, over the last 5 years, in pandemic preparedness.
| Virology|| |
On April 15 and April 17, 2009, the Centers for Disease Control and Prevention  (CDC) identified two cases of human infection with a swine-origin influenza A (H1N1) virus. The World Organization for Animal Health reports  that Swine Influenza strain has not been isolated in pigs. This strain can be transmitted from human to human  and causes the normal symptoms of influenza.  Basically these viruses causing pig's flue are classified as influenza A, B, and C. Transmission mainly occurs between pigs and pigs and humans. The viruses are 80-120 nm in diameter.  Of the three genera of influenza viruses that cause human flu, two also cause influenza in pigs, with influenza virus A being common in pigs and influenza virus C being rare. Influenza virus B has not been reported in pigs. Within influenza virus A and C, the strains found in pigs and humans are largely distinct, although due to reassortment there have been transfers of genes among strains crossing swine, avian, and human species boundaries.
| Epidemiology|| |
Swine-origin influenza A (H1N1) virus in humans have been identified in swine in the United States since 1998, , and 12 cases of human infection with such viruses were identified in the United States from 2005 through 2009.  As of May 5, 2009, a total of 642 cases of human infection with a swine-origin influenza A (H1N1) virus have been identified in the United States, and other additional cases have been identified in Mexico, Canada, and South-East Asia.  On April 25, the WHO  declared a public health emergency of international concern, and on April 26, the United States declared a public health emergency. On April 29, the WHO raised the pandemic influenza phase from 4 to 5, indicating that human-to-human transmission of the virus was occurring in at least two countries in one WHO region. The observation  that 60% of patients were 18 years of age or younger suggests that children and young adults may be more susceptible to swine-origin influenza A infection than are older persons or that because of differences in social networks, transmission to older persons has been delayed. It is also possible that elderly persons may have some level of cross-protection against swine-origin influenza A infection from preexisting antibodies against other influenza A (H1N1) viruses, as suggested by serologic studies of the 1976 swine influenza vaccine. , A potential case-ascertainment bias may also exist, with more young people being tested as part of outbreaks of swine-origin influenza A infection in schools  and fewer older persons being tested for influenza. However, the epidemic is evolving rapidly, and the number of confirmed cases is an underestimate of the number of cases that have occurred. The age of patients with confirmed swine-origin influenza A  infection ranged from 3 months to 81 years. A total of 40% of patients were between the ages of 10 and 18 years, and only 5% of patients were 51 years of age or older. Among the patients for whom clinical information was available, the most common symptoms were fever (94%), cough (92%), and sore throat (66%). In addition, 25% of patients had diarrhea and 25% had vomiting. As per the latest report of the Ministry of Health and Family Welfare,  death from swine flu has reached to 1235. Around 123,397 people have been tested in India as on February 1, 2010. In India, 23.3% people who have tested for swine flu are found suffering from swine flu. Also around 4% people who have tested positive for swine flu have died and could not be saved in India. Maharashtra with 317 deaths has seen maximum deaths from swine flu in India. Gujarat also has 242 deaths from swine flu till February 1, 2010. Interestingly Gujarat is the only state where Chief Minister has been tested positive for swine flu. Other Indian states suffering from are Rajasthan (176 deaths), Karnataka (141 deaths), and Delhi (93 deaths).Delhi has the highest number of patients who are tested positive for swine flu, with 9,652 people tested positive. Maharashtra has 5,116 cases of swine flu affected patients and Rajasthan has 2,101 patients who were tested positive for swine flu till February 1, 2010. The states which are severely affected by swine flu have high exposure to foreigners. Also people from these states make more foreign visits. However the trend is changing now. On February 1, 2010, from the 51 patients who tested positive for swine flu, only one has traveled outside India and remaining 50 have infected in the country only.
| Pathogenesis|| |
Swine influenza, also called swine flu, hog flu, and pig flu, refers to influenza caused by those strains of influenza virus,  called swine influenza virus (swine influenza virus), that usually infect pigs. People who work with pigs, especially people with intense exposures, are at increased risk of catching swine flu. In the mid-20 th century, identification of influenza subtypes became possible; this allows accurate diagnosis of transmission to humans. Since then, 50 confirmed transmissions have been recorded. Rarely, these strains of swine flu can pass from human to human. The 2009 H1N1 virus is not zoonotic swine flu, as it is not transmitted from pigs to humans, but from one person to person. In the United States, CDC  advised physicians to "consider swine influenza infection in the differential diagnosis of patients with acute febrile respiratory illness who have either been in contact with persons with confirmed swine flu, or who were in one of the five U.S. states that have reported swine flu cases or in Mexico during the 7 days preceding their illness onset." The modes of transmission of influenza viruses in humans, including swine influenza, are not known but are thought to occur mainly through the dissemination of large droplets and possibly small-particle droplet nuclei  expelled when an infected person coughs. There is also potential for transmission through contact with fomites that are contaminated with respiratory or gastrointestinal material. , Since many patients with swine influenza infection have had diarrhea, the potential for fecal viral shedding and subsequent fecal-oral transmission should be considered and investigated. The incubation period for swine influenza infection appears to range from 2 to 7 days; however, additional information is needed. On the basis of data regarding viral shedding from studies of seasonal influenza, most patients with swine influenza infection might shed virus from 1 day before the onset of symptoms through 5 to 7 days after the onset of symptoms or until symptoms resolve; in young children and in immunocompromised or severely ill patients, the infectious period might be longer.  The clinical spectrum of novel swine influenza infection is both self-limited illness and in severe outcomes, it can lead to respiratory failure and death, which have been observed among identified patients with a wide clinical spectrum similar to that seen among persons infected with earlier strains of swine-origin influenza viruses  and seasonal influenza viruses.  The severe illness and deaths associated with seasonal influenza epidemics are in large part the result of secondary complications, including primary viral pneumonia, secondary bacterial pneumonia (particularly with group A Streptococcus, Staphylococcus aureus, and Strep. pneumoniae), ,3, and exacerbations of underlying chronic conditions.  These same complications may occur with swine influenza infection. Patients who are at highest risk for severe complications of swine influenza infection are children under the age of 5 years, adults 65 years of age or older, children and adults of any age with underlying chronic medical conditions, and pregnant women. ,
| Clinical Features|| |
According to CDC,  in humans the symptoms include fever, cough, sore throat, body aches, headache, chills, and fatigue. The 2009 outbreak has shown an increased percentage of patients reporting diarrhea and vomiting. It has been noted that around 2% of infected individuals  in some countries have developed severe disease, and that this has occurred most commonly in those aged 30-50 years. Many of these severe cases have involved other chronic health conditions; however, between a third and half of the serious cases have occurred in otherwise healthy, young-to-middle-aged people. Overall, the majority of infections have occurred in individuals aged younger than 25 years.
| Laboratory Diagnosis|| |
A diagnosis of confirmed swine flu requires laboratory testing of a respiratory sample (a simple nose and throat swab). The CDC has developed a Swine Influenza Virus Real-Time PCR Detection Panel.  Among the various diagnostic tests, Real-Time PCR, Nucleotide Sequencing, and phylogenetic analyses were used.
The CDC has developed a real-time PCR assay to detect seasonal influenza A, B, H1, H3, and avian H5 serotypes. Primers and probes specific for swine influenza A (H1 and H3 subtypes) were recently developed and tested for use in a modified version of this assay for the detection of human infection with swine influenza viruses.
Nucleotide sequencing and phylogenetic analysis
Amplicons for gene sequencing were generated by reverse transcription, followed by PCR amplification to generate overlapping double-stranded DNA amplicons covering each of eight segments of the influenza virus genome.
Phylogenetic analysis of sequences contained six gene segments (PB2, PB1, PA, HA, NP, and NS) which were found in triple-reassortant swine influenza viruses circulating in pigs. The genes encoding neuraminidase (NA) and M protein (M) were most closely related to those in influenza A viruses circulating in swine populations.
| Prevention|| |
Prevention and control measures for swine influenza are based on our understanding of seasonal human influenza  and consideration of potential modes of transmission.
Prevention of pig to human transmission
The transmission from swine to human is believed to occur mainly in swine farms where farmers are in close contact with live pigs. The use of vaccines on swine to prevent their infection is a major method of limiting swine to human transmission. Risk factors that may contribute to swine-to-human transmission include smoking and not wearing gloves when working with sick animals.
Prevention of human-to-human transmission
Influenza spreads between humans through coughing or sneezing and people touching something with the virus on it and then touching their own nose or mouth. This virus is not transmitted through food. In humans it is most contagious during the first 5 days of the illness although some people, most commonly children, can remain contagious for up to 10 days. Diagnosis can be made by sending a specimen, collected during the first 5 days for analysis. Recommendations to prevent spread of the virus among humans include using standard infection control against influenza. This includes frequent washing of hands with soap and water or with alcohol-based hand sanitizers, especially after being out in public. Experts agree that hand-washing can help prevent viral infections, including ordinary influenza and the swine flu virus. Influenza can spread in coughs or sneezes, but an increasing body of evidence shows small droplets containing the virus can linger on tabletops, telephones, and other surfaces and be transferred via the fingers to the mouth, nose, or eyes. Alcohol-based gel or foam hand sanitizers work well to destroy viruses and bacteria. Anyone with flu-like symptoms such as a sudden fever, cough, or muscle aches should stay away from work or public transportation and should contact a doctor to be tested. Social distancing is another tactic. It means staying away from other people who might be infected and can include avoiding large gatherings, spreading out a little at work, or perhaps staying home and lying low if an infection is spreading in a community. Public health and other responsible authorities have action plans which may request or require social distancing actions depending on the severity of the outbreak.
As of May 5, 2009, the CDC  has recommended that health care workers who provide direct care for patients with known or suspected swine influenza infection should observe contact and droplet precautions, including the use of gowns, gloves, eye protection, face masks, and fit-tested, disposable N95 respirators. In addition, patients with confirmed or suspected swine influenza infection should be placed in a single-patient room with the door kept closed and airborne-infection isolation rooms with negative-pressure handling should be used whenever an aerosol-generating procedure is being performed. 
| Treatment|| |
Presently government of India recommends tamiflue as a drug of choice which is available at all government health bodies. Human influenza A is susceptible to both oseltamivir and zanamivir, two antiviral medications approved for the prevention and treatment of influenza in the United States. Two classes of antiviral medication are available for the treatment of seasonal human influenza: neuraminidase inhibitors (oseltamivir and zanamivir) and adamantanes (rimantadine and amantadine). During the 2008-2009 influenza season, almost all circulating human influenza A (H1N1) viruses in the United States were resistant to oseltamivir.  However, genetic and phenotypic analyses indicate that swine influenza is susceptible to oseltamivir and zanamivir but resistant to the adamantanes.  The FDA has issued an emergency-use authorization that approves the use of oseltamivir to treat influenza in infants under the age of 1 year (treatment that is normally approved for those 1 year of age or older) and for chemoprophylaxis in infants older than 3 months of age (chemoprophylaxis that is normally approved for children 1 year of age or older) [Table 1]. 
|Table 1 :Swine-origin influenza antiviral medication dosing recommendations|
Click here to view
Swine flue vaccine
It's considered a major medical breakthrough - India's first home made swine flu vaccine named Vaxiflu-S 33 , (0.5ml i.m) is the first indigenous influenza vaccine in India since Independence. Its side effects, experts say, are minor which include fever, aches, and mild soreness. However, one in a million could be exposed to the risk of the Guillain Barre Syndrome - a rare neurological disorder. This vaccine is mainly for those above the age of 18. Trials for use by children will start in the future. Another vaccine called 'Nasovac' is the first intra-nasal vaccine for swine flu, produced in Pune, India. Nasovac  is available for Rs. 158 per dose, which can be used for adults and children above three years. At present no side effects of the vaccine are known, but not indicated in pregnant woman and lactating mothers.
| Conclusion|| |
Prevention and control measures for swine influenza are based on our understanding of seasonal human influenza and consideration of potential modes of transmission. Clinicians are advised to see the H1N1 Influenza Center (NEJM.org) and the CDC Website (http://www.cdc.gov/h1n1flu/) for changes in guidance for testing, treatment, and infection control.
| References|| |
|1.||"Swine influenza update. Available from: http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/121407.htm )". The Merck Veterinary Manual. [cited in 2008]. http://www.merckvetmanual.com/mvm/index.jsp? cfile=htm/bc/121407.htm [last retrieved on 2009 Apr 30]. |
|2.||World health organisization, Posted by New York Times, Journal Watch Editors, 2009; June 11th. |
|3.||Influenza A. (H1N1) - update 12. Geneva: World Health Organization, 2009. Available from: http://www.who.int/csr/don/2009_05_03a/en/index.html [last accessed on 2009 May 26]. |
|4.||Swine influenza. World Health Organization. Available from: http://www.who.int/mediacentre/news/statements/2009/h1n1_20090427/en/index.html. [last cited on 2009 Apr 27]. |
|5.||"Influenza A (H1N1) frequently asked questions" ( http://www.who.int/csr/disease/swineflu/faq/en/index.html Who.int. [last retrieved on 2009 May 7]. |
|6.||Heinen PP. "Swine influenza: A zoonosis. Available from: http://www.vetscite.org/publish/articles/000041/print.html". Veterinary Sciences Tomorrow. ISSN 1569-0830 http://www.worldcat.org/issn/15690830. "Influenza B and C viruses are almost exclusively swine influenza virus isolated from man, although influenza C virus has also been isolated from pigs and influenza B has recently been isolated from seals" [last cited on 2003 Sep 15]. |
|7.||International Committee on Taxonomy of Viruses. "The Universal Virus Database, version4: Influenza A". Available from: http://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/00.046.0.01.htm [last cited on 2009 July 29]. |
|8.||Heinen PP. "Swine influenza: a zoonosis. Available from: ( http://www.vetscite.org/publish/articles/000041/print.html )". Veterinary Sciences Tomorrow. ISSN 1569- 0830 ( http://www.worldcat.org/issn/1569-0830 ). http://www.vetscite.org/publish/articles/000041/print.html [last cited on 2003 Sep 15]. |
|9.||Olsen CW. The emergence of novel swine influenza viruses in North America. Virus Res 2002;85:199-210. |
|10.||Vincent AL, Ma W, Lager KM, Janke BH, Richt JA. Swine influenza viruses: A North American perspective. Adv Virus Res 2008;72:127-54. |
|11.||Shinde V, Bridges CB, Uyeki TM, Shu B, Balish A, Xu X, et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 2009;360:2616-25. |
|12.||David R. Hillyard,. Novel swine-origin influenza A (H1N1) virus investigation team. N Engl J Med 2009;360:25. |
|13.||Cate TR, Kasel JA, Couch RB, Six HR, Knight V. Clinical trials of bivalent influenza A/New Jersey/76-A/Victoria/75 vaccines in the elderly. J Infect Dis 1977;136:S518-25. |
|14.||Dolin R, Wise TG, Mazur MH, Tuazon CU, Ennis FA. Immunogenicity and reactogenicity of influenza A/New Jersey/76 virus vaccines in normal adults. J Infect Dis 1977;136:S435-42. |
|15.||Jordan H, Mosquera M, Nair H, France A. Swine-origin influenza A (H1N1) virus infections in a school: New York City, April 2009. MMWR Morb Mortal Wkly Rep 2009;58:1-3. Available from: http://www.cdc.gov/mmwr/preview/ mmwrhtml/mm58d0430a1.htm [last cited on 2009 July 29]. |
|16.||Infocera - Feb 1, 2010 a report. Swine flu death toll reaches 1235 and 28861 tested positive in India. |
|17.||Blachere FM, Lindsley WG, Pearce TA, Anderson SE, Fisher M, Khakoo R, et al. Measurement of airborne influenza virus in a hospital emergency department. Clin Infect Dis 2009;48:438-40. |
|18.||Bean B, Moore B, Sterner B, Petersen L, Gerding DN, Balfour HH Jr. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982;146:47-51. |
|19.||Boone SA, Gerba CP. The occurrence of influenza A virus on household and day care center fomites. J Infect 2005;51:103-9. |
|20.||Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: A review of volunteer challenge studies. Am J Epidemiol 2008;167:775-85. |
|21.||Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: A review of the literature. Clin Infect Dis 2007;44:1084-8. |
|22.||Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG, Bridges CB, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006;12:894-9. |
|23.||McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006;19:571-82. |
|24.||O′Brien KL, Walters MI, Sellman J, Quinlisk P, Regnery H, Schwartz B, et al. Severe pneumococcal pneumonia in previously healthy children: The role of preceding influenza infection. Clin Infect Dis 2000;30:784-9. |
|25.||Fiore AE, Shay DK, Broder K, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep 2008;57:1-60. |
|26.||Centers for Disease Control and Prevention. 2008-09 Influenza prevention & control recommendations: Influenza vaccination coverage levels. Available from: http://www.cdc.gov/flu/professionals/acip/coveragelevels.htm [last accessed on 2009 May 26]. |
|27.||Influenza vaccines. Wkly Epidemiol Rec 2005;80:279-87. |
|28.||Centers for Disease Control and Prevention (CDC). Update: Infections with a swine-origin influenza A (H1N1) virus - United States and other countries, April 28, 2009. MMWR Morb Mortal Wkly Rep 2009;58:431-3. |
|29.||Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: Implications for control in health care settings. Clin Infect Dis 2003;37:1094-101. |
|30.||Ryan MA, Christian RS, Wohlrabe J. Handwashing and respiratory illness among young adults in military training. Am J Prev Med 2001;21:79-83. |
|31.||Centers for Disease Control and Prevention (CDC). Update: Influenza activity - United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine. MMWR Morb Mortal Wkly Rep 2009;58:369-74. |
|32.||Centers for Disease Control and Prevention (CDC). Update: Drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep 2009;58:433-5. |
|33.||Inactivated Influenza Vaccine (Whole Virion) IP (Pandemic Influenza (H1N1) 2009 Monovalent Vaccine).India′s first swine flu vaccine, NDTV Correspondent, Friday June 4, 2010, New Delhi. http://www.ndtv.com/news/redirect/url.php?from=servicesWidget |
|34.||Nasovac Vaccine: First Made in India Vaccine for Swine Flu launched. Wednesday, July 21, 2010. http://www.weeksupdate.com/2010/07/nasovac-vaccine-first-made-in-india.html |
|This article has been cited by|
||Effect of the Miaoyao Fanggan sachet-derived isorhamnetin on TLR2/4 and NKp46 expression in mice
| ||Wang, H. and Zhang, Q. and Liang Cheng, M. and Ma, L. and Zhi Meng, Q. and Duan, L. and Chen, Y. and Wu Tan, J. and Chen, M. and Ting Liang, T. and Jun Li, G. and Li Li, J. |
| ||Journal of Ethnopharmacology. 2012; 144(1): 138-144 |
||Pandemic influenza - Indian experience
| ||Suri, J.C., Sen, M.K. |
| || Lung India. 2011; 28(1): 2-4 |